The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Nov 2022)
Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
Abdeslam Jaafari,
Abdeslam Jaafari,
Subramani Srinivasan,
Subramani Srinivasan,
Mounir Tilaoui
Affiliations
Abdeslam Jaafari
Laboratory of Biological Engeneering, Sultan Moulay Slimane University, Beni Mellal, Morocco
Abdeslam Jaafari
Lab of Bioprocess-Biointerfaces, Sultan Moulay Slimane University, Beni Mellal, Morocco
Subramani Srinivasan
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Chidambaram, Tamilnadu, India
Subramani Srinivasan
Postgraduate and Research Department of Biochemistry, Government Arts College for Women, Krishnagiri, Tamilnadu, India
Mounir Tilaoui
Pharmaceutical and Molecular Biotechnology Research Center, Waterford Institute of Technology, Waterford, Ireland
DOI
https://doi.org/10.3389/fphar.2022.1067022
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
cancer
pharmacogenomics
data analysis
epigenetics
bioinformatics
WeChat QR code
Close